Back

Persistent CCL3 expression sustains neutrophil recruitment and contributes to delayed wound healing in advanced age

Rocliffe, H. R.; Nawilaijaroen, Y.; Shinkov, V.; Pellicoro, A.; Walmsley, S.; Cash, J. L.

2026-05-29 immunology
10.64898/2026.05.28.727592 bioRxiv
Show abstract

Delayed wound healing in advanced age is associated with prolonged inflammation, but the mechanisms that impair inflammatory resolution in this context remain poorly defined. Neutrophils are essential for early repair, but their persistence is predicted to disrupt resolution and delay healing. Here we show that aged mice exhibit impaired wound closure accompanied by sustained neutrophil infiltration from days 7-14 post-injury, long after neutrophils have resolved in young wounds. In aged skin, macrophage abundance and neutrophil-macrophage interactions were reduced, consistent with reduced macrophage-mediated clearance. Instead, neutrophils preferentially localised to perivascular regions, consistent with ongoing recruitment. Transcriptomic profiling demonstrated that young wounds transitioned from inflammatory to reparative programs, whereas aged wounds retained inflammatory signatures, including enrichment for neutrophil chemotaxis and LPS-response pathways. Notably, Ccl3, Cxcl2 and Cxcl3 remained elevated in aged wounds. Analysis of human chronic ulcers identified macrophages as a major source of these transcripts, and aged mouse wounds possessed more CCL3+ macrophages than in young. Targeted blockade of CCL3 beginning at day 4 post-injury reduced neutrophil accumulation, accelerated wound closure, and rescued key features of age-impaired healing, when administered after the initial inflammatory phase. Together, these findings identify persistent CCL3 expression as a contributor to sustained neutrophil recruitment and impaired repair in advanced age. Therapeutically targeting this pathway offers a strategy to restore timely resolution and improve healing outcomes.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Aging Cell
144 papers in training set
Top 0.7%
9.9%
2
Immunity
58 papers in training set
Top 0.6%
8.3%
3
eLife
5422 papers in training set
Top 10%
7.0%
4
Journal of Experimental Medicine
106 papers in training set
Top 0.4%
6.2%
5
Science Translational Medicine
111 papers in training set
Top 0.3%
6.2%
6
Nature Communications
4913 papers in training set
Top 34%
4.8%
7
Cell Reports
1338 papers in training set
Top 10%
4.8%
8
JCI Insight
241 papers in training set
Top 1.0%
4.2%
50% of probability mass above
9
Journal of Clinical Investigation
164 papers in training set
Top 1%
3.5%
10
Matrix Biology
28 papers in training set
Top 0.1%
3.5%
11
Science Immunology
81 papers in training set
Top 0.7%
3.0%
12
Arthritis & Rheumatology
33 papers in training set
Top 0.2%
2.3%
13
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 29%
2.0%
14
Nature Immunology
71 papers in training set
Top 1%
1.9%
15
Journal of Investigative Dermatology
42 papers in training set
Top 0.3%
1.7%
16
EMBO Molecular Medicine
85 papers in training set
Top 2%
1.7%
17
Cell Reports Medicine
140 papers in training set
Top 4%
1.6%
18
PLOS Biology
408 papers in training set
Top 14%
1.2%
19
Annals of the Rheumatic Diseases
32 papers in training set
Top 0.5%
1.2%
20
Nature Aging
51 papers in training set
Top 1%
1.2%
21
Cell Stem Cell
57 papers in training set
Top 2%
1.1%
22
Advanced Science
249 papers in training set
Top 17%
0.9%
23
Science Advances
1098 papers in training set
Top 27%
0.9%
24
Molecular Therapy
71 papers in training set
Top 2%
0.9%
25
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.8%
26
iScience
1063 papers in training set
Top 30%
0.8%
27
Cell
370 papers in training set
Top 18%
0.7%
28
PLOS ONE
4510 papers in training set
Top 70%
0.7%
29
Nature
575 papers in training set
Top 17%
0.7%
30
Scientific Reports
3102 papers in training set
Top 77%
0.7%